Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
Select Content Type
Clinical Guidelines
Authored By
na
Interests
Pediatric Medicine
Internal/Family Medicine
Book Detail
Publisher
American Medical Association
volume
3
ISSN
2574-3805 ; Electronic
Actions
Download in App
Event Data
{"article_title":"Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.","author":"na","journal_title":"JAMA network open","issn":"2574-3805 ; Electronic","isbn":"","publication_date":"20201201","volume":"3","issue":"12","first_page":"e2029411","page_count":"","accession_number":"33315113","doi":"10.1001\/jamanetworkopen.2020.29411","publisher":"American Medical Association","doctype":"Journal Article; Research Support","subjects":"Medicine - Pediatrics","interest_area":["Pediatric Medicine"," Internal\/Family Medicine"],"abstract":"Genotype-guided prescribing in pediatrics could prevent adverse drug reactions and improve therapeutic response. Clinical pharmacogenetic implementation guidelines are available for many medications commonly prescribed to children. Frequencies of medication prescription and actionable genotypes (genotypes where a prescribing change may be indicated) inform the potential value of pharmacogenetic implementation.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=33315113&authtype=shib&custid=ns346513"}
Genotype-guided prescribing in pediatrics could prevent adverse drug reactions and improve therapeutic response. Clinical pharmacogenetic implementation guidelines are available for many medications commonly prescribed to children. Frequencies of medication prescription and actionable genotypes (genotypes where a prescribing change may be indicated) inform the potential value of pharmacogenetic implementation.
